This inventor holds 1 USPTO granted patent. Top assignee: Laboratory Corporation of America Holdings. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Alan Remaley: Innovator in Lipoprotein Detection
Introduction
Alan Remaley is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of biosample analysis, particularly in the detection and quantification of abnormal lipoproteins. His work is essential for advancing medical diagnostics and improving patient care.
Latest Patents
Alan Remaley holds 1 patent for his innovative methods and systems to detect and quantify the amount of LP-X and other abnormal lipoproteins in a biosample using NMR spectroscopy. This patent describes methods and systems for determining constituents in biosamples by NMR spectroscopy, specifically focusing on lipoprotein constituents LP-X, LP-Y, and LP-Z in blood plasma and serum.
Career Highlights
Alan is currently employed at Laboratory Corporation of America Holdings, where he continues to develop and refine his innovative techniques. His work has the potential to significantly impact the field of lipidology and enhance the understanding of lipoprotein-related diseases.
Collaborations
Throughout his career, Alan has collaborated with esteemed colleagues such as James D. Otvos and Irina Shalaurova. These partnerships have fostered a collaborative environment that promotes innovation and scientific advancement.
Conclusion
Alan Remaley's contributions to the field of lipoprotein detection through his patented methods highlight his role as a key innovator in medical diagnostics. His work continues to pave the way for advancements in understanding and treating lipoprotein-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile